The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Orbimed Capital Ii Llc since year 2005.
The trader's CIK number is 1281668.
At the time of this reporting, Orbimed Capital Ii Llc is the Director of Supernus Pharmaceuticals Inc .
(stock ticker symbol SUPN).
See this page for all insider trading activities at Supernus Pharmaceuticals Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2013-02-13||SUPN||Supernus Pharmaceuticals Inc||Sale||150,000||7.58||1,136,400|
|2013-02-12||SUPN||Supernus Pharmaceuticals Inc||Sale||152,183||7.52||1,144,720|
|2012-12-18||SUPN||Supernus Pharmaceuticals Inc||Sale||100,000||7.08||707,700|
|2012-12-17||SUPN||Supernus Pharmaceuticals Inc||Sale||197,815||6.85||1,354,637|
|2006-05-24||GIVN||Given Imaging Ltd||Sale||22,500||18.14||408,150|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Orbimed Capital Ii Llc (Director of Supernus Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.